• Login
    View Item 
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    •   UMB Digital Archive
    • School, Graduate
    • Theses and Dissertations All Schools
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    mTOR, a therapeutic target in head and neck squamous cell carcinoma

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Find Full text
    Author
    Amornphimoltham, Panomwat
    Advisor
    Sauk, John J.
    Date
    2007
    Type
    dissertation
    
    Metadata
    Show full item record
    Abstract
    Squamous cell carcinoma of the head and neck (HNSCC) is the 6 th most common cancer in the developed world, affecting nearly 44,000 patients and resulting in ∼11,000 deaths each year in the US alone. Despite significant advance in conventional therapies, the survival rate of HNSCC patients had barely improved over the past three decades, reflecting the urgent need for the development of novel and more effective treatment strategies. A better understanding of the mechanism involved in tumorigenesis has afforded the opportunity to initiate new molecular targeting strategies for cancer treatment. In this regard, we observed that persistent activation of the Akt pathway is a frequent event in HNSCC. Akt promotes cell proliferation by coordinating mitogenic signaling with energy and nutrient-sensing pathways controlling protein synthesis though the mammalian target of rapamycin (mTOR). These findings prompted us to investigate the consequences of interfering with mTOR function in HNSCC. We found that rapamycin rapidly reduced the elevated levels of phospho-S6, a downstream mTOR effector, in HNSCC cells in vitro and displayed a potent anti-tumoral effect in HNSCC xenografts in vivo. However, rapamycin did not affect HNSCC cells growth in vitro, raising the possibility that, as for other cancers, rapamycin may not target cancer cells directly but may instead act based on its anti-angiogenic properties. To address this issue, we have utilized a retro-inhibition approach consisting in the expression of a rapamycin-resistant mTOR mutant in HNSCC cells, while retaining wild-type mTOR in host-derived stromal cells, which hence remained rapamycin-sensitive. This reverse-pharmacology strategy revealed that HNSCC cells are the primary target of HNSCC in vivo, and enabled monitoring the direct consequences of inhibiting mTOR within the complex tumor microenvironment. We also used the well-established two-step chemical carcinogenesis mouse model to explore the effectiveness of rapamycin in HNSCC using an animal model which reflects the complexity of the clinical setting. Rapamycin administration caused a dramatic decrease in the tumor burden, and prolonged the survival of tumor-bearing mice. Collectively, these findings define the Akt-mTOR pathway as a therapeutic target for HNSCC, thus raising the possibility of exploring the clinical activity of rapamycin in HNSCC patients.
    Description
    University of Maryland, Baltimore. Oral and Experimental Pathology. Ph.D. 2007
    Keyword
    Health Sciences, Oncology
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/1038
    Collections
    Theses and Dissertations All Schools
    Theses and Dissertations School of Medicine

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.